# Pharmacokinetic and Therapeutic Adaptation of Linezolid in the Treatment of Multi-Resistant Tuberculosis

> **NCT02778828** · NA · COMPLETED · sponsor: **Fondation Hôpital Saint-Joseph** · enrollment: 31 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **DRUG:** Linezolid

## Key facts

- **NCT ID:** NCT02778828
- **Lead sponsor:** Fondation Hôpital Saint-Joseph
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-04
- **Primary completion:** 2017-12-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2019-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02778828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02778828, "Pharmacokinetic and Therapeutic Adaptation of Linezolid in the Treatment of Multi-Resistant Tuberculosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02778828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*